<DOC>
	<DOCNO>NCT00912808</DOCNO>
	<brief_summary>The purpose study find medication increase level brain chemical call acetylcholine improve balance reduce fall patient parkinson 's disease problem poor balance frequently fall nearly fall daily basis . Donepezil , drug approve treatment Alzheimer 's dementia , reduce fall subject Parkinson 's disease balance impairment .</brief_summary>
	<brief_title>Cholinergic Augmentation Frequently Falling Subjects With Parkinson 's Disease</brief_title>
	<detailed_description>This trial double-blinded cross-over design compare donepezil placebo 40 subject idiopathic Parkinson 's disease report frequent fall near fall ( &gt; 2/week ) . The purpose study find medication increase level brain chemical call acetylcholine improve balance reduce fall patient parkinson 's disease problem poor balance frequently fall nearly fall daily basis . Donepezil , drug approve treatment Alzheimer 's dementia , reduce fall subject Parkinson 's disease balance impairment .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<mesh_term>Cholinergic Agents</mesh_term>
	<criteria>Age 21 Diagnosis Parkinson 's disease Treated dopaminergic medication least 1 year Must ambulatory ( use walker cane ) No obvious remediable cause fall Falls basis nonCNS etiology ( cardiogenic , orthopedic , peripheral neuropathy , etc ) Dementia present ( MMSE &lt; 25 ) Not take cholinergic anticholinergic medication 10 day prior screen visit No Warfarin use</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>parkinson disease</keyword>
	<keyword>fall</keyword>
</DOC>